Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 39 (3) , 486-492
- https://doi.org/10.1053/ajkd.2002.31392
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Add-on angiotensin receptor blockade with maximized ACE inhibitionKidney International, 2001
- Captopril-induced reduction of serum levels of transforming growth Factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patientsAmerican Journal of Kidney Diseases, 1999
- Urinary transforming growth factor-β in patients with glomerular diseasesPediatric Nephrology, 1997
- Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin systemKidney International, 1997
- Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells.Journal of Clinical Investigation, 1996
- The role of proteinuria in the progression of chronic renal failureAmerican Journal of Kidney Diseases, 1996
- Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic miceDiabetes, 1996
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.Journal of Clinical Investigation, 1993
- Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatmentJournal Of Hypertension, 1992